22157.jpg
Global Head and Neck Cancer Therapeutics Market Report 2022: Historical Data 2017-2020, Base year of 2021, Estimates for 2022, & Forecasts 2023-2027
May 20, 2022 04:38 ET | Research and Markets
Dublin, May 20, 2022 (GLOBE NEWSWIRE) -- The "Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods v/s Treatment Type), By Treatment Type (By Disease Indication, By Route of...
Global Market for Cancer Cachexia
Global Cancer Cachexia Market Report 2022: Market to Reach $2.9 Billion by 2027 - North America and Europe Constitute Major Regions, Asia-Pacific Exhibits the Fastest Growth
May 13, 2022 08:13 ET | Research and Markets
Dublin, May 13, 2022 (GLOBE NEWSWIRE) -- The "Cancer Cachexia - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Cancer Cachexia Market to...
new_logo.png
Oncology Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
May 12, 2022 08:00 ET | Graphical Research
Pune, India, May 12, 2022 (GLOBE NEWSWIRE) -- The global oncology market size is anticipated to rise substantially through 2028, attributed to the rising incidence of cancer across many regions...
22157.jpg
United Kingdom Private Healthcare Self-Pay Market Report 2022: Impact of Covid-19 & Reasons for Self-pay Market Growth
May 11, 2022 05:48 ET | Research and Markets
Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Private Healthcare Self-Pay UK Market Report: Fourth Edition" report has been added to ResearchAndMarkets.com's offering. This report delivers...
22157.jpg
Outlook on the CAR-T Cell Therapies Industry - In-depth Review of the Various Patents and Affiliated IP Documents
April 25, 2022 05:58 ET | Research and Markets
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapies: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions,...
TIP_link_300x300.jpg
Metastatic Cancer Drug Market Size Worth $68.34Bn, Globally, by 2028 at 4.2% CAGR - Exclusive Report by The Insight Partners
April 13, 2022 05:19 ET | The Insight Partners
New York, April 13, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Cancer...
Color Logo.png
Global Lung Cancer Therapeutics Market was valued at USD 9.92 billion in 2021 and projected to grow at a CAGR of 10.74% during the forecast period 2022-2028 : Greyviews
April 13, 2022 04:30 ET | GreyViews
Pune, India, April 13, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
Global Pegfilgrastim Biosimilars Market
Global Pegfilgrastim Biosimilars Market Report (2022 to 2031) - Featuring Mylan, Biocon and Mundipharma Among Others
March 22, 2022 05:23 ET | Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Report 2022: By Application, By Distribution" report has been added to ResearchAndMarkets.com's offering. This...
120114 PONO Capital.png
Benuvia, a Leading Drug Developer Focused on Pharmaceutical Cannabinoids, with the FDA Approved Drug SYNDROS®, Signs Definitive Agreement to Become a Publicly Traded Company through a Business Combination with Pono Capital Corp
March 18, 2022 06:00 ET | Pono Capital Corp.
Benuvia, a leading drug developer focused on pharmaceutical cannabinoids has entered into a definitive business combination agreement with Pono Capital Corp (Nasdaq: PONOU)The transaction implies a...
22157.jpg
Global $4,037 Million Pegfilgrastim Biosimilars Markets, Analysis & Forecasts, 2015-2020, 2025F, 2030F
March 16, 2022 06:38 ET | Research and Markets
Dublin, March 16, 2022 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030, By Application, Distribution Channel" report has been added to...